Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Bermekimab by XBiotech for Rheumatoid Arthritis: Likelihood of Approval
Bermekimab is under clinical development by XBiotech and currently in Phase II for Rheumatoid Arthritis. According to GlobalData, Phase II...